Hettmann, Thore
Gillies, Stephen D.
Kleinschmidt, Martin
Piechotta, Anke
Makioka, Koki
Lemere, Cynthia A. http://orcid.org/0000-0002-2983-7870
Schilling, Stephan
Rahfeld, Jens-Ulrich
Lues, Inge
Article History
Received: 3 November 2019
Accepted: 8 February 2020
First Online: 24 February 2020
Competing interests
: T.H. is employed by Vivoryon Therapeutics A.G. J.U.R., S.S. and S.G. are advisors for Vivoryon Therapeutics A.G. C.A.L. was a non-paid member of the scientific advisory board for Vivoryon Therapeutics A.G. and receives murine anti-pE3-Aβ antibodies from Vivoryon as a gift in kind for her research. I.L. holds stock options from Vivoryon Therapeutics A.G. M.K., A.P. and K.M. declare no competing interests.